Department of Neurology, Royal Devon and Exeter Hospital, Exeter, UK.
Transfusion. 2010 May;50(5):1003-6. doi: 10.1111/j.1537-2995.2010.02614.x. Epub 2010 Mar 5.
To date there have been four instances of infection transmitted through blood transfusions derived from individuals who later developed variant Creutzfeldt-Jakob disease (vCJD). The identification of further transmission of vCJD through this route would have important implications for risk assessment and public health.
Through the UK Transfusion Medicine Epidemiology Review (TMER) the fate of blood donations from individuals who develop vCJD is traced and recipients of labile components are identified. The details of recipients are cross-checked with the register of vCJD cases held at the National CJD Surveillance Unit (NCJDSU) to identify any linkage between donors and recipients. In the reverse study, when individuals with vCJD are found to have a history of blood transfusion the donors of the transfused blood components are traced and their details cross-checked with the vCJD register to identify any missed or unrecognized linkage between donors and recipients.
A case of vCJD has been identified with a history of blood transfusion in infancy. The donors who provided the components transfused cannot be identified, but a blood donor known to have donated blood to another individual who subsequently developed vCJD could have been a donor to the index case.
The at-risk donor is alive 20 years after the relevant donation and continued to donate for some years, until identified as at risk, with 27 other blood components issued for use in patients, none of whom are known to have developed vCJD.
Circumstantial evidence has raised the possibility that the case in this report represents a further instance of transfusion transmission of vCJD. However, detailed investigation indicates that the pattern of events may have occurred by chance and disease in this individual may have been caused by transmission of bovine spongiform encephalopathy infection, as is the presumed cause in other primary cases of vCJD.
迄今为止,已有四起通过从后来发生变异型克雅氏病(vCJD)的个体中获得的血液输血传播的感染病例。通过这种途径进一步传播 vCJD 将对风险评估和公共卫生产生重要影响。
通过英国输血医学流行病学审查(TMER),追踪了发生 vCJD 的个体的献血命运,并确定了不稳定成分的接受者。通过与国家克雅氏病监测单位(NCJDSU)持有的 vCJD 病例登记册交叉核对接受者的详细信息,以确定供体和接受者之间是否存在关联。在反向研究中,当发现患有 vCJD 的个体有输血史时,会追踪输注血液成分的供体,并将其详细信息与 vCJD 登记册交叉核对,以确定供体和接受者之间是否存在遗漏或未被识别的关联。
已确定一例 vCJD 病例,该病例在婴儿期有输血史。无法确定提供输注成分的供体,但已知有一名献血者曾向另一名随后发生 vCJD 的个体献血,该献血者可能是该索引病例的供体。
在相关捐赠后 20 年,处于风险中的供体仍然存活,并继续献血数年,直到被确定为处于风险中,有 27 个其他血液成分用于患者,据了解,他们均未患有 vCJD。
间接证据提出了该报告中的病例可能代表 vCJD 输血传播的进一步实例的可能性。然而,详细的调查表明,事件的模式可能是偶然发生的,该个体的疾病可能是由于牛海绵状脑病感染的传播引起的,这与其他原发性 vCJD 病例的推测原因相同。